Multiple Kinase Small Molecule Inhibitor Tinengotinib (TT-00420) Alone or With Chemotherapy Inhibit the Growth of SCLC. Li H, Tang C, Zhao P, Zhong R, et al. Cancer Sci 2025;116:951-965.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li H, Tang C, Zhao P, Zhong R, et al. Multiple Kinase Small Molecule Inhibitor Tinengotinib (TT-00420) Alone or With Chemotherapy Inhibit the Growth of SCLC. Cancer Sci 2025;116:951-965.
PMID: 39817471